Compound ID | 409
LY228238
Class: Beta-lactam (cephalosporin, carbacephem [loracarbef derivative])
| Spectrum of activity: | Gram-positive & Gram-negative |
| Description: | KASHER, J. S.; J. A. EUDALY, R. JOHNSON & J. SHOUFLER: Pharmacokinetics of orally absorbed beta-lactam antibiotics LY228238 and LY257128 in laboratory animals. Program and Abstracts of the 28th Intersci. Conf. on Antimicrob. Agents Chemother., No. 535, p. 202, Los Angeles, Oct. 23-26, 1988 |
| Institute where first reported: | Eli Lilly, USA |
| Year first mentioned: | 1988 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Low oral bioactivity in monkeys compared with rats and mice |
| External links: | |
| Citation: | https://www.jstage.jst.go.jp/article/antibiotics1968/42/11/42_11_1653/_pdf/-char/en |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.